LXRP - Lexaria Bioscience Corp.

Other OTC - Other OTC Delayed Price. Currency in USD

Lexaria Bioscience Corp.

740 McCurdy Road
Unit 100
Kelowna, BC V1X 2P7

SectorConsumer Defensive
IndustryPackaged Foods
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Christopher A. BunkaChairman & CEO223.28kN/A1962
Mr. John M. DochertyPres & Director195.74kN/A1969
Mr. Allan Spissinger C.A., CPACFO, Corp. Sec. & Treasurer112.38kN/A1969
Dr. Edward ErgenzingerChief Legal Advisor and Sr. Advisor of InnovationN/AN/AN/A
Dr. Philip AinslieAdvisor & ConsultantN/AN/AN/A
Amounts are as of December 31, 2019 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Lexaria Bioscience Corp. focuses on the development of its proprietary nutrient infusion technologies for the production of superfoods. It operates in two segments, Intellectual Property Licensing and Consumer Products. The company develops and licenses DehydraTECH, a patented lipid nutrient infusion technology that improves taste, rapidity, and delivery of bioactive compounds that include cannabinoids, vitamins, non-steroidal anti-inflammatory drugs, nicotine, and other molecules. It is also involved in the development, production, and distribution of enhanced functional food and supplement products under the ViPova, TurboCBD, ChrgD+ and Lexaria Energy brands. The company was formerly known as Lexaria Corp. and changed its name to Lexaria Bioscience Corp. in April 2016. Lexaria Bioscience Corp. was founded in 2004 and is headquartered in Kelowna, Canada.

Corporate Governance

Lexaria Bioscience Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.